Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Long-Term Real-World Experience of CPX-351 in Combined French-Italian Cohorts Identified High Rate of Negative Measurable Residual Disease (MRD) and Prolonged Overall Survival

Blood (2023) 142 (Supplement 1): 4255.

https://doi.org/10.1182/blood-2023-177951

Published: 2023

Journal Articles

AGILE: A Global, Randomized, Double-Blind, Phase 3 Study of Ivosidenib + Azacitidine Versus Placebo + Azacitidine in Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation

Pau Montesinos, Christian Recher, Susana Vives, Ewa Zarzycka, Jianxiang Wang, Giambattista Bertani, Michael Heuser, Rodrigo T. Calado, Andre C. Schuh, Su-Peng Yeh, Scott R. Daigle, Jianan Hui, Vickie Zhang, Shuchi S. Pandya, Diego A. Gianolio, Stephane de Botton, Hartmut Döhner

Blood (2021) 138 (Supplement 1): 697.

https://doi.org/10.1182/blood-2021-147805

Published: 2021

Journal Articles

Genetic Landscape and Clonal Evolution Patterns of CEBPA -Mutated Acute Myeloid Leukaemia Based on Next-Generation Sequencing: A Retrospective Analysis

Livia Leuzzi, Valentina Mancini, Silvio Marco Veronese, Laura Pezzetti, Valentina Motta, Michele Nichelatti, Rosa Greco, Giambattista Bertani, Marco Montillo, Alessandro Beghini, Roberto Cairoli

Blood (2021) 138 (Supplement 1): 2363.

https://doi.org/10.1182/blood-2021-149248

Published: 2021

Journal Articles

CPX-351 Induction in Secondary Acute Myeloblastic Leukemia: Extended Follow up from the Italian Compassionate Use Program

Blood (2021) 138 (Supplement 1): 1262.

https://doi.org/10.1182/blood-2021-153028

Published: 2021

Journal Articles

Therapy-Related AML (t-AML), a Heterogeneous Disease: Multicenter Analysis on Biological and Clinical Differences between Cases Following Breast Cancer and Lymphoma Treatment

Giambattista Bertani, MD, Fabio Guolo, MD, Valentina Mancini, MD, Rosa Greco, MD, Paola Minetto, MD PhD, Monica Passannante, MD, Roberto Massimo Lemoli, MD, Roberto Cairoli

Blood (2020) 136 (Supplement 1): 31.

https://doi.org/10.1182/blood-2020-138866

Published: 2020

Journal Articles

Enasidenib, an Oral Therapy in Mutant IDH2 Relapsed/Refractory Acute Myeloid Leukemia: A Real-Life Single Center Experience

Marta Riva, Lorenzo Rizzo, MD, Valentina Mancini, MD, Rosa Greco, MD, Giambattista Bertani, MD, Elisa Zucchetti, MD, Elisa Diral, MD, Michele Nichelatti, PhD, Silvio Marco Veronese, Giovanni Grillo, MD, Roberto Cairoli

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-141987

Published: 2020

Journal Articles

Administration of Plerixafor in Poor Mobilizers Allows Mobilization of Haematopoietic Progenitors: Clonogenic Potential and Engraftment Analysis

Laura Pezzetti, MSc, Giambattista Bertani, MD, Liliana Intropido, MSc, Tiziana Lamacchia, MSc, Mariateresa Pugliano, MD, Elisabetta Bice Volpato, MD, Elisa Zucchetti, MD, Giovanni Grillo, MD, Roberto Cairoli, MD

Blood (2019) 134 (Supplement_1): 5633.

https://doi.org/10.1182/blood-2019-125055

Published: 2019

Journal Articles

Treatment of Elderly Patients with Acute Promyelocytic Leukemia: A Real Life Experience of the "Rete Ematologica Lombarda"

Valentina Mancini, MD, Erika Borlenghi, MD, Livia Leuzzi, MD, Claudia Basilico, MD, Massimo Bernardi, MD, Patrizia Zappasodi, MD, Monica Fumagalli, MD, Elisabetta Todisco, MD PhD, Chiara Cattaneo, MD, Federico Lussana, MD, Giambattista Bertani, MD, Erika Ravelli, MD, Nicola Fracchiolla, Mauro Turrini, Giuseppe Rossi, Silvia Cantoni, Roberto Cairoli, MD

Blood (2019) 134 (Supplement_1): 3862.

https://doi.org/10.1182/blood-2019-130089

Published: 2019

Journal Articles

Retrospective Monocentric Study on Acute Myeloid Leukemias with Complex Karyotype: Clinical Outcomes and Cytogenetic Features

Giovanni Grillo, MD, Ivana Lotesoriere, MD, Elisa Zucchetti, MD, Valentina Mancini, MD, Barbara Forno, MD, Giambattista Bertani, MD, Elena Inzoli, MD, Silvia Soriani, Roberto Cairoli, MD

Blood (2017) 130 (Supplement 1): 5550.

https://doi.org/10.1182/blood.V130.Suppl_1.5550.5550

Published: 2017

Journal Articles

Impact of FLT3-ITD Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Giovanni Grillo, MD, Elisa Zucchetti, MD, Elena Inzoli, MD, Valentina Mancini, MD, Barbara Forno, MD, Ivana Lotesoriere, MD, Giambattista Bertani, MD, Roberto Cairoli, MD

Blood (2017) 130 (Supplement 1): 5553.

https://doi.org/10.1182/blood.V130.Suppl_1.5553.5553

Published: 2017

Journal Articles

Refining Hellström-Lindberg Score: Which Patients Could Benefit from Standard Dose EPO?

Marta Riva, MD, Gianluigi Reda, MD, Emanuele Ravano, MD, Ramona Cassin, MD, Mariarita Sciumè, MD, Pierangelo Spedini, MD, Giambattista Bertani, MD, Michele Nichelatti, PhD, Agostino Cortelezzi, Prof, Roberto Cairoli, MD, Alfredo Molteni, MD

Blood (2017) 130 (Supplement 1): 2981.

https://doi.org/10.1182/blood.V130.Suppl_1.2981.2981

Published: 2017

Journal Articles

Long-Term Surveillance of Allogeneic and Autologous Hemopoietic Stem Cell Transplant Recipients Affected by Primary Occult Hepatitis B Virus Infection

Roberto Cairoli, Luigi Mancini, Giambattista Bertani, Maria Luisa De Angelis, Nadia Vantaggiato, Clara Cesana, Valentina Mancini, Enrica Morra, Maria Lisa Ribero, Alessandro Tagger

Blood (2010) 116 (21): 3350.

https://doi.org/10.1182/blood.V116.21.3350.3350

Published: 2010

Journal Articles

Clinical Follow-up Demonstrates Differential Accuracy of Flow Cytometry and Cytomorphology for the Detection of Hematologic Malignancy in Hypercellular Body Cavity Fluids.

Clara Cesana, Catherine Klersy, Barbara Scarpati, Bruno Brando, Elisabetta Volpato, Giambattista Bertani, Maurizio Faleri, Annamaria Nosari, Silvia Cantoni, Ursula Ferri, Linda Scampini, Claudia Barba, Giuliana Lando, Enrica Morra, Roberto Cairoli

Blood (2009) 114 (22): 5018.

https://doi.org/10.1182/blood.V114.22.5018.5018

Published: 2009

NARROW

Long-Term Real-World Experience of CPX-351 in Combined French-Italian Cohorts Identified High Rate of Negative Measurable Residual Disease (MRD) and Prolonged Overall Survival

AGILE: A Global, Randomized, Double-Blind, Phase 3 Study of Ivosidenib + Azacitidine Versus Placebo + Azacitidine in Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation

Genetic Landscape and Clonal Evolution Patterns of CEBPA -Mutated Acute Myeloid Leukaemia Based on Next-Generation Sequencing: A Retrospective Analysis

CPX-351 Induction in Secondary Acute Myeloblastic Leukemia: Extended Follow up from the Italian Compassionate Use Program

Therapy-Related AML (t-AML), a Heterogeneous Disease: Multicenter Analysis on Biological and Clinical Differences between Cases Following Breast Cancer and Lymphoma Treatment

Enasidenib, an Oral Therapy in Mutant IDH2 Relapsed/Refractory Acute Myeloid Leukemia: A Real-Life Single Center Experience

Administration of Plerixafor in Poor Mobilizers Allows Mobilization of Haematopoietic Progenitors: Clonogenic Potential and Engraftment Analysis

Treatment of Elderly Patients with Acute Promyelocytic Leukemia: A Real Life Experience of the "Rete Ematologica Lombarda"

Retrospective Monocentric Study on Acute Myeloid Leukemias with Complex Karyotype: Clinical Outcomes and Cytogenetic Features

Impact of FLT3-ITD Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Refining Hellström-Lindberg Score: Which Patients Could Benefit from Standard Dose EPO?

Long-Term Surveillance of Allogeneic and Autologous Hemopoietic Stem Cell Transplant Recipients Affected by Primary Occult Hepatitis B Virus Infection

Clinical Follow-up Demonstrates Differential Accuracy of Flow Cytometry and Cytomorphology for the Detection of Hematologic Malignancy in Hypercellular Body Cavity Fluids.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only